Search research articles
Contact Us
Filters
Showing results (41-50 of 154) with videos related to
Page
of 16
Sort By:
Annals of Epidemiology
|
July 28, 2020
Partitioning of time trends in prevalence and mortality of bladder cancer in the United States
Igor Akushevich, Arseniy P Yashkin, Brant A Inman, et al.
Urologic Oncology
|
January 24, 2021
Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladder cancer during BCG shortage
Dominic C Grimberg, John Dudinec, Ankeet Shah, et al.
Cancer
|
May 13, 2009
Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality
Brant A Inman, Viet-Tan Tran, Yves Fradet, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
May 14, 2019
Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer
Laura Meleis, Russell Moore, Brant A Inman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 7, 2017
Reply to 'It May be Time to Abandon Urine Tests for Bladder Cancer'
Hideki Furuya, Charles J Rosser, Brant A Inman, et al.
European Urology Focus
|
July 21, 2017
Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis
Joseph J Fantony, Ajay Gopalakrishna, Megan Van Noord, et al.
BJU International
|
February 9, 2012
An examination of the dynamic changes in prostate-specific antigen occurring in a population-based cohort of men over time
Brant A Inman, Jingyu Zhang, Nilay D Shah, et al.
The Journal of Urology
|
October 9, 2003
Routine nasogastric tubes are not required following cystectomy with urinary diversion: a comparative analysis of 430 patients
Brant A Inman, François Harel, Rabi Tiguert, et al.
European Urology Oncology
|
August 15, 2019
The Cost to Medicare of Bladder Cancer Care
Frank A Sloan, Arseniy P Yashkin, Igor Akushevich, et al.
Urologic Oncology
|
November 26, 2019
Longitudinal patterns of cost and utilization of medicare beneficiaries with bladder cancer
Frank A Sloan, Arseniy P Yashkin, Igor Akushevich, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 154) with videos related to
Sort By:
Page
of 16
Annals of Epidemiology
|
July 28, 2020
Partitioning of time trends in prevalence and mortality of bladder cancer in the United States
Igor Akushevich, Arseniy P Yashkin, Brant A Inman, et al.
Urologic Oncology
|
January 24, 2021
Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladder cancer during BCG shortage
Dominic C Grimberg, John Dudinec, Ankeet Shah, et al.
Cancer
|
May 13, 2009
Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality
Brant A Inman, Viet-Tan Tran, Yves Fradet, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
May 14, 2019
Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer
Laura Meleis, Russell Moore, Brant A Inman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 7, 2017
Reply to 'It May be Time to Abandon Urine Tests for Bladder Cancer'
Hideki Furuya, Charles J Rosser, Brant A Inman, et al.
European Urology Focus
|
July 21, 2017
Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis
Joseph J Fantony, Ajay Gopalakrishna, Megan Van Noord, et al.
BJU International
|
February 9, 2012
An examination of the dynamic changes in prostate-specific antigen occurring in a population-based cohort of men over time
Brant A Inman, Jingyu Zhang, Nilay D Shah, et al.
The Journal of Urology
|
October 9, 2003
Routine nasogastric tubes are not required following cystectomy with urinary diversion: a comparative analysis of 430 patients
Brant A Inman, François Harel, Rabi Tiguert, et al.
European Urology Oncology
|
August 15, 2019
The Cost to Medicare of Bladder Cancer Care
Frank A Sloan, Arseniy P Yashkin, Igor Akushevich, et al.
Urologic Oncology
|
November 26, 2019
Longitudinal patterns of cost and utilization of medicare beneficiaries with bladder cancer
Frank A Sloan, Arseniy P Yashkin, Igor Akushevich, et al.
Page
of 16